The purpose of this study is to determine the link between serum irisin level and subclinical atherosclerosis in patients with Behcet’s illness and to compare serum irisin to other modalities for diagnosing subclinical atherosclerosis and endothelial dysfunctions. This evidence concerns the gene FNDC5 and atherosclerosis.